We are live on ! Find out more
MD icon

Pediatrix Medical

304 hedge funds and large institutions have $5.49B invested in Pediatrix Medical in 2013 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 104 increasing their positions, 121 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 18

106% more call options, than puts

Call options by funds: $29M | Put options by funds: $14M

10% more funds holding

Funds holding: 276304 (+28)

9% more capital invested

Capital invested by funds: $5.05B → $5.49B (+$437M)

14% less repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 121

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

98.63% less ownership

Funds ownership: 201%102.38% (-99%)

Holders
304
Holders Change
+28
Holders Change %
+10.14%
% of All Funds
8.82%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
48
Increased
104
Reduced
121
Closed
18
Calls
$29M
Puts
$14M
Net Calls
+$14.9M
Net Calls Change
+$19.4M
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
201
Securian Asset Management
Minnesota
$776K -$25.8K -480 -3%
PCP
202
Perimeter Capital Partners
Georgia
$776K
MC
203
Montag & Caldwell
Georgia
$765K -$74.1K -1,380 -9%
COPPSERS
204
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$754K -$13.7K -255 -2%
TH
205
Timber Hill
Connecticut
$750K +$279K +5,206 +59%
Truist Financial
206
Truist Financial
North Carolina
$741K -$25.2K -469 -3%
NI
207
Numeric Investors
Massachusetts
$721K +$725K +13,500 New
BlackRock
208
BlackRock
New York
$719K -$8.16K -152 -1%
NCA
209
NCM Capital Advisers
North Carolina
$705K -$134K -2,500 -16%
Calamos Advisors
210
Calamos Advisors
Illinois
$705K +$129K +2,400 +22%
PNC Financial Services Group
211
PNC Financial Services Group
Pennsylvania
$693K +$1.18K +22 +0.2%
HSBC Holdings
212
HSBC Holdings
United Kingdom
$688K -$14.6K -272 -2%
BUB
213
BBVA USA Bancshares
Texas
$638K +$26.8K +499 +4%
Legal & General Group
214
Legal & General Group
United Kingdom
$622K +$119K +2,224 +24%
SKK
215
Shepherd Kaplan Krochuk
Massachusetts
$605K
SCM
216
Shelton Capital Management
Colorado
$591K
PCM
217
Parsons Capital Management
Rhode Island
$550K -$10.7K -200 -2%
SCM
218
Stevens Capital Management
Pennsylvania
$535K +$537K +10,014 New
WTNA
219
Wilmington Trust National Association
Delaware
$531K -$25.2K -470 -5%
FA
220
FDx Advisors
Illinois
$521K +$134K +2,494 +34%
Tudor Investment Corp
221
Tudor Investment Corp
Connecticut
$509K +$511K +9,530 New
Jacobs Levy Equity Management
222
Jacobs Levy Equity Management
New Jersey
$507K +$510K +9,500 New
EIM
223
Essex Investment Management
Massachusetts
$506K -$6.01K -112 -1%
QCMC
224
Quantum Capital Management (California)
California
$490K +$493K +9,184 New
PP
225
PDT Partners
New York
$480K +$105K +1,956 +28%

MD Hedge Fund Activity: Q4 2013 in Review

304 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2013, worth a combined $5.49B — up 8.7% from $5.05B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new MD positions and 18 closed out — a net gain of 30 holders — while 104 added to existing stakes and 121 trimmed.

The largest buyer was EARNEST Partners, opening a new position worth an estimated $134M. The largest seller was Fidelity Investments, cutting an estimated $57.1M.

  • 304 institutional investors held Pediatrix Medical (MD) as of Q4 2013, up from 276 in Q3 2013.
  • Funds reported $5.49B of Pediatrix Medical stock for Q4 2013, up 8.7% quarter-over-quarter.
  • 48 funds opened new Pediatrix Medical positions in Q4 2013 and 18 closed out, a net change of +30 holders.
  • The largest Pediatrix Medical buyer in Q4 2013 was EARNEST Partners, an estimated $134M added.
  • The largest Pediatrix Medical seller in Q4 2013 was Fidelity Investments, an estimated $57.1M sold.

Based on aggregated 13F filings for Q4 2013.